Effect of metal-based anticancer drugs on wild type and metallothionein null cell lines

BioMetals

Volumn 16, Issue 3, 2003, Pages 403-409

  Mahboobi, H ^a   Viarengo, A ^a   Colangelo, D ^a   Osella, D ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Chemoresistance; Metal based anticancer drugs; Metallothionein; Mouse embryo fibroblasts

Indexed keywords

ANTINEOPLASTIC AGENT; CADMIUM; CADMIUM CHLORIDE; CELL PROTEIN; COPPER; COPPER SULFATE; GEMCITABINE; METALLOTHIONEIN; PACLITAXEL; REACTIVE OXYGEN METABOLITE; VINBLASTINE; ZINC; ZINC CHLORIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESISTANCE; DRUG SENSITIVITY; ELECTROPHORESIS; EMBRYO; FIBROBLAST; METAL BINDING; MOUSE; NONHUMAN; NULL CELL; OXIDATIVE STRESS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; STRAIN DIFFERENCE; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CADMIUM CHLORIDE; CARBOPLATIN; CELL DIVISION; CELL LINE; CHLORIDES; CISPLATIN; COPPER SULFATE; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FERROUS COMPOUNDS; FIBROBLASTS; INHIBITORY CONCENTRATION 50; METALLOTHIONEIN; METALS, HEAVY; MICE; MICE, KNOCKOUT; PACLITAXEL; SPECTROPHOTOMETRY, ATOMIC; SURVIVAL ANALYSIS; SURVIVAL RATE; VINBLASTINE; ZINC COMPOUNDS;

ANIMALIA; SIMIAE; SIMIAN VIRUS 40;

EID: 0037412056     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022586310104     Document Type: Article

References (24)

1. Basu A, Lazo JS. 1990 A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol Lett 50, 123-135.
2. Cherian MG, Howell SB, Imura N et al. 1994 Contemporary issues in toxicology. Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 126, 1-5.
3. 2]. Indian J Chem 8, 193-194.
4. Green KJ, Goldman RD. 1983 The effects of taxol on cytoskeletal components in cultured fibroblasts and epithelial cells. Cell Motil 3(4), 283-305.
5. Harrison RC, McAuliffe CA, Zaki AM. 1980 An efficient route for the preparation of highly soluble platinum (II) antitumor agents. Inorg Chim Acta 46, L15-L16.
6. He T, Wei D, Fabris D, Fenselau C. 2000 Intracellular sequestration of anti-tumor drugs by metallothionein. Cell Mol Biol 46(2), 383-392.
7. Klaassen CD, Liu J. 1998 Metallothionein transgenic and knockout mouse models in the study of cadmium toxicity. J Toxicol Sci 23 (Suppl 2), 97-102.
8. Klaassen CD, Liu J, Choudhuri S. 1999 Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39, 267-294.
9. Kelley SL, Basu A, Teicher BA, Hacher MP, Hamer DH, Lazo JS. 1988 Overexpression of metallothionein confers resistance to anticancer drugs. Science (Washington DC). 241, 1813-1815.
10. Kondo Y, Woo ES, Michalska AE, Choo KHA, Lazo JS. 1995 Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55, 2021-2023.
11. Laemmli UF. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
12. Lazo JS, Pitt BR. 1995 Metallothioneins and cell death by anticancer drugs. Annu Rev Pharmacol Toxicol 35, 635-653.
13. Lazo JS, Kondo Y, Dellapiazza D, Michalska AE, Choo KHA, Pitt BR. 1995 Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in MT I and II genes. J Biol Chem 270, 5506-5510.
14. Lippert B, ed. 1999 Cisplatin. Chemistry and biochemistry of a leading anticancer drug. Weinheim: Wiley - VCH.
15. Matsui K, Fukuoka M. 1992 New antitumor antimetabolites-Gemcitabine and DMDC. Gan To Kagaku Ryoho 19(13), 2127-2132.
16. Mosmann T. 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65, 55-63.
17. Osella D, Ferrali M, Zanello P, Laschi F, Fontani M, Nervi C, Cavigiolio, G. 2000 On the mechanism of the antitumor activity of ferrocenium derivatives. Inorg Chim Acta 306, 42-48.
18. Cassino C, Cavigioglio G, Colangero D, Galeotti F, Ghiglia A, Osella D, Tabbí G. 2001 Water stability and cytotoxic activity relationship of a series of ferrocenium salts. Characterization of the radical production during the degradation process. J Inorg Biochem 86, 171.
19. Perego P, Gatti L, Caserini C, Supino R, Colangelo D, Leone R, Spinelli S, Farrell N, Zunino F. 1999 The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. J Inorg Biochem 77(1-2), 59-64.
20. Shaw CF, Stillman MJ, Suzuki KT. 1991 An overview of metalthiolate complex formation in metallothioneins. In: Stillman MJ, Shaw III CF, Suzuki KT, eds. Metallothioneins: synthesis, structure and properties of metallothioneins, phytochelatins and metal-thiolate complexes. Weinheim: VCH Verlagsgellschaft; 1-30.
21. Suzuki KT. 1996 Structure and function of metallothionein. Nippon Rinsho 54(1), 33-39.
22. Viarengo A, Ponzano E, Dondero F, Fabbri R. 1997 A simple spectrophotometric method for metallothionein evaluation in marine organisms: an application to Mediterranean and Antarctic molluscs. Mar Environ Res 44(1), 69-84.
23. Viarengo A, Burlando B, Cavaletto M, Marchi B, Ponzano E, Blasco J. 1999 Role of metallothionein against oxidative stress in the mussel Mytilus galloprovincialis. Am J Physiol 277, R1612-R1619.
24. Zhou XJ, Rahmani R. 1992 Preclinical and clinical pharmacology of vinca alkaloids. Drugs 44(Suppl 4, 1-16), 66-69.